These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3. Lutton CW; Gudvangen RJ; Nealon TJ; Paque RE; Gauntt CJ J Med Virol; 1985 Dec; 17(4):345-57. PubMed ID: 3001222 [TBL] [Abstract][Full Text] [Related]
5. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration. Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068 [TBL] [Abstract][Full Text] [Related]
7. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes. Guthrie M; Lodge PA; Huber SA Cell Immunol; 1984 Oct; 88(2):558-67. PubMed ID: 6091924 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes. Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926 [TBL] [Abstract][Full Text] [Related]
10. In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis. Godeny EK; Gauntt CJ Am J Pathol; 1987 Nov; 129(2):267-76. PubMed ID: 2823612 [TBL] [Abstract][Full Text] [Related]
11. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy. Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3. Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124 [TBL] [Abstract][Full Text] [Related]
13. Lee YG; Park JH; Jeon ES; Kim JH; Lim BK J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433 [TBL] [Abstract][Full Text] [Related]
14. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis. Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238 [TBL] [Abstract][Full Text] [Related]
15. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response. Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842 [TBL] [Abstract][Full Text] [Related]
17. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication. Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210 [TBL] [Abstract][Full Text] [Related]
18. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice. Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552 [TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647 [TBL] [Abstract][Full Text] [Related]
20. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. Beck MA; Kolbeck PC; Shi Q; Rohr LH; Morris VC; Levander OA J Infect Dis; 1994 Aug; 170(2):351-7. PubMed ID: 8035022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]